ArticleOncoTargets and therapy2018

Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study.

Andrés Redondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.